| TRANSITION PERIOD COMPARATIVE DATA |
TRANSITION PERIOD COMPARATIVE DATA The following table shows selected financial information for the transition period ended December 31, 2022 and the comparative period ended December 31, 2021 (the “Comparative Period”). The Comparative Period information is derived from the Company’s unaudited, condensed consolidated financial statements and filed with the SEC on Quarterly Report on Form 10-Q on February 4, 2022, and can be referred to for additional details.
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
December 31, 2022 |
|
Nine Months Ended
December 31, 2021 |
|
|
|
(Unaudited) |
| Condensed income statement |
|
|
|
| Total revenues |
$ |
922,569 |
|
|
$ |
897,804 |
|
| Total costs and expenses |
888,492 |
|
|
867,891 |
|
| Loss on impairment |
(5,187) |
|
|
(24,835) |
|
| Gain (loss) on disposal of assets |
(480) |
|
|
1,388 |
|
| Earnings (losses) from unconsolidated affiliates, net |
1,461 |
|
|
(1,413) |
|
| Operating income |
29,871 |
|
|
5,053 |
|
| Total other income (expense), net |
(8,792) |
|
|
(8,357) |
|
| Income tax expense |
(7,494) |
|
|
(8,034) |
|
| Net income attributable to noncontrolling interests |
(57) |
|
|
(141) |
|
| Net income (loss) attributable to Bristow Group Inc. |
13,528 |
|
|
(11,479) |
|
| Earnings (loss) per common share: |
|
|
|
| Basic |
$ |
0.48 |
|
|
$ |
(0.40) |
|
| Diluted |
$ |
0.47 |
|
|
$ |
(0.40) |
|
| Weighted average shares of common stock outstanding: |
|
|
|
| Basic |
28,066 |
|
|
28,634 |
|
| Diluted |
28,574 |
|
|
28,634 |
|
|
|
|
|
| Condensed cash flows |
|
|
|
| Net cash provided by (used in) operating activities |
$ |
(13,304) |
|
|
$ |
118,277 |
|
| Net cash used in investing activities |
(44,142) |
|
|
(9,528) |
|
| Net cash used in financing activities |
(20,732) |
|
|
(59,592) |
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(24,153) |
|
|
(2,774) |
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
(102,331) |
|
|
46,383 |
|
| Cash, cash equivalents and restricted cash at beginning of period |
266,014 |
|
|
231,079 |
|
| Cash, cash equivalents and restricted cash at end of period |
$ |
163,683 |
|
|
$ |
277,462 |
|
|
|
|
|
| Condensed balance sheets |
|
|
|
| Total assets |
$ |
1,812,001 |
|
|
$ |
1,864,789 |
|
| Total liabilities |
$ |
1,025,062 |
|
|
$ |
1,020,477 |
|
| Total stockholders’ equity |
$ |
786,939 |
|
|
$ |
844,312 |
|
|